Pay in 4 interest-free payments of $5.93 Learn more
Ships within 48 hours · Estimated delivery Aug 26 - Aug 31
Psychopharmacology 241, 97107
42.0 42.1 Nag S, Quivey JM, Earle JD, et al
2 market cap positions of Big Pharma, both were well aware that one-trick ponies dont last forever in this industry and have been investing not only in the next generation of the GLP-1 drugs but in other therapeutic areas as well. Valuation, risk, and investment The surge in GLP-1 drug development is redefining the nature of dealmaking across the biopharma sector
If you are reading this, there is a good chance you are either currently using a GLP-1 receptor agonist or considering one
You don't need an appointment
US$ 27.26
US$ 20.52
US$ 24.94
US$ 24.15
US$ 22.57
US$ 22.82
US$ 22.35
US$ 26.24
US$ 29.36
